This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Belluscura has developed the X-PLOR, a lightweight, portable oxygen delivery device aimed at treating the millions of people globally suffering from chronic lung diseases. The company plans to launch this novel and cost-effective device in the US in 2019, with Europe to follow.

Back to company profile

Financial data drawn from last filed accounts don't necessarily reflect current trading activity. Financials provided by Company Check.

Accounts

2016 2017 2018 2019 2020
Turnover £32.73k £285.92k £186.25k £90.98k £0
Cash £973.17k £146.52k £403.71k £730.6k £367.64k
Increase in Cash £1.8m £-867.48k £274.36k £331.94k £-376.28k

Profit & Loss

2016 2017 2018 2019 2020
Audit Fees £15.69k £16.47k £26.33k £26.27k £26.23k
Cost of Sales £25.33k £296.74k £191.8k £80.86k £0
Depreciation £5.01k £5.05k £7.22k £75.96k £75.35k
Directors Emoluments £188.15k £448.82k £295.58k £257.32k £285.83k
Dividends - - - - -
Export - - - - £0
Gross Profit £7.4k £-10.82k £-5.55k £10.12k £0
Interest Payments £0 £0 £0 £26.3k £23.3k
Operating Profit £-743.1k £-2.24m £-1.12m £-1.07m £-1.38m
Pretax Profit £-743.1k £-2.24m £-1.12m £-1.1m £-1.4m
Profit after Tax £-743.1k £-2.24m £-1.12m £-1.1m £-1.4m
Retained Profit £-743.1k £-2.24m £-1.12m £-1.1m £-1.4m
Taxation £0 £0 £0 £0 £0
Turnover £32.73k £285.92k £186.25k £90.98k £0
Wages & Salaries £307.73k £766.76k £588.76k £571.56k £722.94k

Balance Sheet

2016 2017 2018 2019 2020
Intangible Assets £136.21k £126.59k £1.38m £2.07m £2.92m
Bank Loans & Overdrafts £0 £0 £0 £0 £0
Cash £973.17k £146.52k £403.71k £730.6k £367.64k
Miscellaneous Current Assets £0 £0 £0 £0 £0
Miscellaneous Current Liabilities £45.85k £260.44k £78.32k £190.36k £51.95k
Other Debtors £66.57k £56.12k £10.66k £0 £121.26k
Other Long Term Finance £0 £0 £0 £294.3k £229.86k
Other Short Term Finance £137k £169.33k £0 £58.02k £110.73k
Stock £3.43k £62.76k £97.16k £0 £0
Tangible Accounts £35.25k £1.04m £22.16k £350.81k £275.46k
Total Current Assets £1.06m £326.04k £535.84k £776.25k £507.37k
Total Current Liabilities £313.9k £1.08m £191.71k £272.39k £162.69k
Total Fixed Assets £171.46k £1.17m £1.4m £2.43m £3.19m
Total Long Term Finance £0 £0 £0 £294.3k £238.97k
Trade Creditors £131.05k £646.88k £113.39k £24.01k £0
Trade Debtors £12.38k £60.62k £24.31k £3.99k £0

Capital & Reserves

2016 2017 2018 2019 2020
Profit & Loss Account Reserve £-743.1k £141.99k £-985.15k £-2.01m £1.9m
Called up share capital £91.6k £127.44k £345.95k £458.29k £581.93k
Revaluation Reserve £0 £0 £0 £0 £0
Shareholder Funds £913.11k £420.6k £1.74m £2.64m £3.3m
Sundry Reserves £1.56m £151.18k £2.38m £116.64k £116.64k

Cash

2016 2017 2018 2019 2020
Increase in Cash £1.8m £-867.48k £274.36k £331.94k £-376.28k
Net Cash Flow Before Financing £-15.83k £722.36k £-2.42m £-1.47m £-1.88m
Net Cash Flow From Financing £1.81m £-1.59m £2.69m £1.8m £1.51m
Net Cash Flow From Operations £-545.75k £-1.41m £-1.81m £-708.59k £-1.04m

Other Financials

2016 2017 2018 2019 2020
Net Assets £913.11k £420.6k £1.74m £2.64m £3.3m
Net Worth £776.9k £294.01k £366.29k £560.37k £381.17k
Total Assets £1.23m £1.5m £1.93m £3.2m £3.7m
Total Liabilities £313.9k £1.08m £191.71k £566.7k £401.66k
Working Capital £741.65k £-750.61k £344.13k £503.86k £344.68k

Ratios

2016 2017 2018 2019 2020
Creditor Days 1.46k% 902.73% 221.6% 96.07% 0%
Current Debt Ratio 0.34% 2.55% 0.1% 0.1% 0.04%
Current Ratio 3.36% 0.3% 2.8% 2.85% 3.12%
Debtor Days 137.74% 84.6% 47.51% 15.97% 0%
Equity In Percentage 83.7% 30.7% 312.4% 233.8% 421.6%
Gearing 0% 0% 0% 11.2% 7.2%
Liquidity Ratio Or Acid Test 3.35% 0.24% 2.28% 2.84% 3.11%
Pre Tax Profit Margin -2.27k% -783.34% -601.98% -1.21k% 0%
Return On Capital Employed -81.38% -532.49% -64.32% -37.44% -39.5%
Return On Net Assets Employed -81.38% -532.49% -64.32% -41.63% -42.36%
Return On Total Assets Employed -60.56% -149.58% -57.95% -34.26% -37.77%
Sales Or Net Working Capital 0% 0% 0% 0% 0%
Stock Turnover Ratio 10.46% 21.95% 52.16% 0% 0%
Total Debt Ratio 0.34% 2.55% 0.1% 0.21% 0.12%